nodes	percent_of_prediction	percent_of_DWPC	metapath
Lansoprazole—Esomeprazole—Barrett's esophagus	0.169	0.5	CrCtD
Lansoprazole—Omeprazole—Barrett's esophagus	0.169	0.5	CrCtD
Lansoprazole—ATP4A—Barrett's esophagus	0.145	1	CbGaD
Lansoprazole—ATP4A—Esomeprazole—Barrett's esophagus	0.0572	0.26	CbGbCtD
Lansoprazole—ATP4B—Esomeprazole—Barrett's esophagus	0.0572	0.26	CbGbCtD
Lansoprazole—Rabeprazole—Omeprazole—Barrett's esophagus	0.0367	0.167	CrCrCtD
Lansoprazole—Esomeprazole—Omeprazole—Barrett's esophagus	0.0367	0.167	CrCrCtD
Lansoprazole—Pantoprazole—Esomeprazole—Barrett's esophagus	0.0367	0.167	CrCrCtD
Lansoprazole—Rabeprazole—Esomeprazole—Barrett's esophagus	0.0367	0.167	CrCrCtD
Lansoprazole—Pantoprazole—Omeprazole—Barrett's esophagus	0.0367	0.167	CrCrCtD
Lansoprazole—Omeprazole—Esomeprazole—Barrett's esophagus	0.0367	0.167	CrCrCtD
Lansoprazole—ATP4B—Omeprazole—Barrett's esophagus	0.0337	0.153	CbGbCtD
Lansoprazole—ATP4A—Omeprazole—Barrett's esophagus	0.0337	0.153	CbGbCtD
Lansoprazole—CYP2C18—Omeprazole—Barrett's esophagus	0.0085	0.0386	CbGbCtD
Lansoprazole—CYP1B1—Omeprazole—Barrett's esophagus	0.00804	0.0365	CbGbCtD
Lansoprazole—ATP4A—gastric juice—Barrett's esophagus	0.00735	0.624	CbGeAlD
Lansoprazole—ABCG2—Omeprazole—Barrett's esophagus	0.00382	0.0173	CbGbCtD
Lansoprazole—CYP1A1—Omeprazole—Barrett's esophagus	0.00353	0.016	CbGbCtD
Lansoprazole—ATP4A—Secretion of Hydrochloric Acid in Parietal Cells—GAST—Barrett's esophagus	0.00322	0.25	CbGpPWpGaD
Lansoprazole—CYP2C19—Esomeprazole—Barrett's esophagus	0.0029	0.0132	CbGbCtD
Lansoprazole—CYP2C8—Omeprazole—Barrett's esophagus	0.00204	0.00924	CbGbCtD
Lansoprazole—CYP2C19—Omeprazole—Barrett's esophagus	0.00171	0.00775	CbGbCtD
Lansoprazole—CYP1A2—Omeprazole—Barrett's esophagus	0.00158	0.00715	CbGbCtD
Lansoprazole—CYP2C9—Omeprazole—Barrett's esophagus	0.00142	0.00645	CbGbCtD
Lansoprazole—CYP3A4—Esomeprazole—Barrett's esophagus	0.0014	0.00636	CbGbCtD
Lansoprazole—ABCB1—Omeprazole—Barrett's esophagus	0.00138	0.00626	CbGbCtD
Lansoprazole—CYP2D6—Omeprazole—Barrett's esophagus	0.0013	0.00589	CbGbCtD
Lansoprazole—ATP4B—digestive system—Barrett's esophagus	0.00103	0.0874	CbGeAlD
Lansoprazole—CYP3A4—Omeprazole—Barrett's esophagus	0.000826	0.00375	CbGbCtD
Lansoprazole—ATP4B—Ion transport by P-type ATPases—ATP4A—Barrett's esophagus	0.000808	0.0627	CbGpPWpGaD
Lansoprazole—ATP4A—epithelium—Barrett's esophagus	0.00059	0.05	CbGeAlD
Lansoprazole—CYP4A11—digestive system—Barrett's esophagus	0.000557	0.0472	CbGeAlD
Lansoprazole—Esomeprazole—ATP4A—Barrett's esophagus	0.000509	0.329	CrCbGaD
Lansoprazole—ATP4A—digestive system—Barrett's esophagus	0.000449	0.0381	CbGeAlD
Lansoprazole—CYP2C18—digestive system—Barrett's esophagus	0.000369	0.0313	CbGeAlD
Lansoprazole—Rabeprazole—ATP4A—Barrett's esophagus	0.000368	0.238	CrCbGaD
Lansoprazole—Pantoprazole—ATP4A—Barrett's esophagus	0.000368	0.238	CrCbGaD
Lansoprazole—Omeprazole—ATP4A—Barrett's esophagus	0.0003	0.194	CrCbGaD
Lansoprazole—CYP4A11—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP26A1—Barrett's esophagus	0.000294	0.0228	CbGpPWpGaD
Lansoprazole—CYP4A11—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—Barrett's esophagus	0.000294	0.0228	CbGpPWpGaD
Lansoprazole—CYP4A11—Arachidonic acid metabolism—PTGES—Barrett's esophagus	0.000285	0.0221	CbGpPWpGaD
Lansoprazole—ATP4B—Ion channel transport—ATP4A—Barrett's esophagus	0.00028	0.0217	CbGpPWpGaD
Lansoprazole—MAPT—BDNF signaling pathway—CRTC1—Barrett's esophagus	0.000231	0.0179	CbGpPWpGaD
Lansoprazole—CYP1B1—smooth muscle tissue—Barrett's esophagus	0.000226	0.0192	CbGeAlD
Lansoprazole—CYP4A11—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.000187	0.0145	CbGpPWpGaD
Lansoprazole—CYP4A11—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.000184	0.0143	CbGpPWpGaD
Lansoprazole—CYP1B1—Arachidonic acid metabolism—PTGES—Barrett's esophagus	0.000184	0.0142	CbGpPWpGaD
Lansoprazole—CYP1B1—digestive system—Barrett's esophagus	0.000179	0.0152	CbGeAlD
Lansoprazole—CYP1A1—epithelium—Barrett's esophagus	0.000166	0.0141	CbGeAlD
Lansoprazole—CYP2C18—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.000163	0.0127	CbGpPWpGaD
Lansoprazole—ABCB1—Drug Induction of Bile Acid Pathway—NR1I2—Barrett's esophagus	0.000162	0.0126	CbGpPWpGaD
Lansoprazole—CYP2C18—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.000161	0.0125	CbGpPWpGaD
Lansoprazole—MAPT—Apoptotic cleavage of cellular proteins—APC—Barrett's esophagus	0.000159	0.0123	CbGpPWpGaD
Lansoprazole—CYP2C19—digestive system—Barrett's esophagus	0.000157	0.0133	CbGeAlD
Lansoprazole—CYP4A11—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.000151	0.0117	CbGpPWpGaD
Lansoprazole—CYP2C18—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.000132	0.0103	CbGpPWpGaD
Lansoprazole—CYP1A2—digestive system—Barrett's esophagus	0.000128	0.0109	CbGeAlD
Lansoprazole—CYP1A1—digestive system—Barrett's esophagus	0.000126	0.0107	CbGeAlD
Lansoprazole—MAPT—Apoptotic execution phase—APC—Barrett's esophagus	0.000123	0.00956	CbGpPWpGaD
Lansoprazole—MAPT—Copper homeostasis—APC—Barrett's esophagus	0.000123	0.00956	CbGpPWpGaD
Lansoprazole—CYP2C9—digestive system—Barrett's esophagus	0.000121	0.0103	CbGeAlD
Lansoprazole—CYP1B1—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.00012	0.00933	CbGpPWpGaD
Lansoprazole—ABCG2—Irinotecan Pathway—APC—Barrett's esophagus	0.00012	0.00927	CbGpPWpGaD
Lansoprazole—CYP1B1—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.000119	0.00921	CbGpPWpGaD
Lansoprazole—CYP1A1—Arachidonic acid metabolism—PTGES—Barrett's esophagus	0.000113	0.00878	CbGpPWpGaD
Lansoprazole—ABCG2—HIF-1-alpha transcription factor network—MCL1—Barrett's esophagus	0.000111	0.0086	CbGpPWpGaD
Lansoprazole—CYP2C8—Arachidonic acid metabolism—PTGES—Barrett's esophagus	0.000104	0.00805	CbGpPWpGaD
Lansoprazole—CYP3A4—Drug Induction of Bile Acid Pathway—NR1I2—Barrett's esophagus	0.0001	0.00776	CbGpPWpGaD
Lansoprazole—CYP1B1—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	9.76e-05	0.00757	CbGpPWpGaD
Lansoprazole—ATP4B—Transmembrane transport of small molecules—ATP4A—Barrett's esophagus	9.73e-05	0.00755	CbGpPWpGaD
Lansoprazole—CYP4A11—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Barrett's esophagus	9.68e-05	0.00751	CbGpPWpGaD
Lansoprazole—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—Barrett's esophagus	9.33e-05	0.00723	CbGpPWpGaD
Lansoprazole—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP26A1—Barrett's esophagus	9.33e-05	0.00723	CbGpPWpGaD
Lansoprazole—CYP3A4—digestive system—Barrett's esophagus	9.26e-05	0.00786	CbGeAlD
Lansoprazole—CYP2C19—Arachidonic acid metabolism—PTGES—Barrett's esophagus	9.26e-05	0.00718	CbGpPWpGaD
Lansoprazole—CYP2D6—digestive system—Barrett's esophagus	9.12e-05	0.00773	CbGeAlD
Lansoprazole—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—Barrett's esophagus	8.71e-05	0.00676	CbGpPWpGaD
Lansoprazole—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP26A1—Barrett's esophagus	8.71e-05	0.00676	CbGpPWpGaD
Lansoprazole—ABCB1—epithelium—Barrett's esophagus	8.62e-05	0.00731	CbGeAlD
Lansoprazole—CYP2C9—Arachidonic acid metabolism—PTGES—Barrett's esophagus	8.44e-05	0.00655	CbGpPWpGaD
Lansoprazole—MAPT—LPA receptor mediated events—RELA—Barrett's esophagus	8.16e-05	0.00633	CbGpPWpGaD
Lansoprazole—CYP4A11—Biological oxidations—CYP26A1—Barrett's esophagus	8.04e-05	0.00624	CbGpPWpGaD
Lansoprazole—MAPT—LPA receptor mediated events—CXCL8—Barrett's esophagus	7.69e-05	0.00596	CbGpPWpGaD
Lansoprazole—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—Barrett's esophagus	7.45e-05	0.00577	CbGpPWpGaD
Lansoprazole—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP26A1—Barrett's esophagus	7.45e-05	0.00577	CbGpPWpGaD
Lansoprazole—CYP1A1—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	7.41e-05	0.00575	CbGpPWpGaD
Lansoprazole—CYP1A1—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	7.32e-05	0.00567	CbGpPWpGaD
Lansoprazole—CYP1A2—Arachidonic acid metabolism—PTGES—Barrett's esophagus	7.22e-05	0.0056	CbGpPWpGaD
Lansoprazole—CYP2C18—Biological oxidations—CYP26A1—Barrett's esophagus	7.03e-05	0.00545	CbGpPWpGaD
Lansoprazole—CYP2C18—Metapathway biotransformation—CYP26A1—Barrett's esophagus	6.93e-05	0.00538	CbGpPWpGaD
Lansoprazole—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	6.8e-05	0.00527	CbGpPWpGaD
Lansoprazole—CYP2C8—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	6.71e-05	0.0052	CbGpPWpGaD
Lansoprazole—ABCB1—digestive system—Barrett's esophagus	6.56e-05	0.00556	CbGeAlD
Lansoprazole—Hypoglycaemia—Esomeprazole—Barrett's esophagus	6.53e-05	0.00131	CcSEcCtD
Lansoprazole—Hypoglycaemia—Omeprazole—Barrett's esophagus	6.53e-05	0.00131	CcSEcCtD
Lansoprazole—MAPT—LKB1 signaling events—TP53—Barrett's esophagus	6.49e-05	0.00503	CbGpPWpGaD
Lansoprazole—Hyponatraemia—Omeprazole—Barrett's esophagus	6.39e-05	0.00128	CcSEcCtD
Lansoprazole—Hyponatraemia—Esomeprazole—Barrett's esophagus	6.39e-05	0.00128	CcSEcCtD
Lansoprazole—Diplopia—Esomeprazole—Barrett's esophagus	6.37e-05	0.00128	CcSEcCtD
Lansoprazole—Osteoarthritis—Esomeprazole—Barrett's esophagus	6.37e-05	0.00128	CcSEcCtD
Lansoprazole—Osteoarthritis—Omeprazole—Barrett's esophagus	6.37e-05	0.00128	CcSEcCtD
Lansoprazole—Diplopia—Omeprazole—Barrett's esophagus	6.37e-05	0.00128	CcSEcCtD
Lansoprazole—Gastrointestinal haemorrhage—Esomeprazole—Barrett's esophagus	6.37e-05	0.00128	CcSEcCtD
Lansoprazole—Gastrointestinal haemorrhage—Omeprazole—Barrett's esophagus	6.37e-05	0.00128	CcSEcCtD
Lansoprazole—Migraine—Omeprazole—Barrett's esophagus	6.27e-05	0.00126	CcSEcCtD
Lansoprazole—Migraine—Esomeprazole—Barrett's esophagus	6.27e-05	0.00126	CcSEcCtD
Lansoprazole—Face oedema—Esomeprazole—Barrett's esophagus	6.15e-05	0.00123	CcSEcCtD
Lansoprazole—Face oedema—Omeprazole—Barrett's esophagus	6.15e-05	0.00123	CcSEcCtD
Lansoprazole—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	6.07e-05	0.0047	CbGpPWpGaD
Lansoprazole—CYP1A1—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	6.01e-05	0.00466	CbGpPWpGaD
Lansoprazole—ABCB1—HIF-1-alpha transcription factor network—MCL1—Barrett's esophagus	6e-05	0.00465	CbGpPWpGaD
Lansoprazole—CYP2C19—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	5.99e-05	0.00464	CbGpPWpGaD
Lansoprazole—ATP4B—Transmembrane transport of small molecules—SLC9A1—Barrett's esophagus	5.97e-05	0.00463	CbGpPWpGaD
Lansoprazole—Blood creatinine increased—Esomeprazole—Barrett's esophagus	5.97e-05	0.00119	CcSEcCtD
Lansoprazole—Blood creatinine increased—Omeprazole—Barrett's esophagus	5.97e-05	0.00119	CcSEcCtD
Lansoprazole—Dry skin—Omeprazole—Barrett's esophagus	5.84e-05	0.00117	CcSEcCtD
Lansoprazole—Dry skin—Esomeprazole—Barrett's esophagus	5.84e-05	0.00117	CcSEcCtD
Lansoprazole—Hypokalaemia—Omeprazole—Barrett's esophagus	5.8e-05	0.00116	CcSEcCtD
Lansoprazole—Hypokalaemia—Esomeprazole—Barrett's esophagus	5.8e-05	0.00116	CcSEcCtD
Lansoprazole—Breast disorder—Esomeprazole—Barrett's esophagus	5.76e-05	0.00115	CcSEcCtD
Lansoprazole—Breast disorder—Omeprazole—Barrett's esophagus	5.76e-05	0.00115	CcSEcCtD
Lansoprazole—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP26A1—Barrett's esophagus	5.75e-05	0.00446	CbGpPWpGaD
Lansoprazole—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—Barrett's esophagus	5.75e-05	0.00446	CbGpPWpGaD
Lansoprazole—Cramp muscle—Omeprazole—Barrett's esophagus	5.74e-05	0.00115	CcSEcCtD
Lansoprazole—Toxic epidermal necrolysis—Esomeprazole—Barrett's esophagus	5.74e-05	0.00115	CcSEcCtD
Lansoprazole—Toxic epidermal necrolysis—Omeprazole—Barrett's esophagus	5.74e-05	0.00115	CcSEcCtD
Lansoprazole—Aspartate aminotransferase increased—Omeprazole—Barrett's esophagus	5.74e-05	0.00115	CcSEcCtD
Lansoprazole—Cramp muscle—Esomeprazole—Barrett's esophagus	5.74e-05	0.00115	CcSEcCtD
Lansoprazole—Aspartate aminotransferase increased—Esomeprazole—Barrett's esophagus	5.74e-05	0.00115	CcSEcCtD
Lansoprazole—Gastritis—Omeprazole—Barrett's esophagus	5.64e-05	0.00113	CcSEcCtD
Lansoprazole—Gastritis—Esomeprazole—Barrett's esophagus	5.64e-05	0.00113	CcSEcCtD
Lansoprazole—Alanine aminotransferase increased—Omeprazole—Barrett's esophagus	5.62e-05	0.00112	CcSEcCtD
Lansoprazole—Muscular weakness—Esomeprazole—Barrett's esophagus	5.62e-05	0.00112	CcSEcCtD
Lansoprazole—Alanine aminotransferase increased—Esomeprazole—Barrett's esophagus	5.62e-05	0.00112	CcSEcCtD
Lansoprazole—Muscular weakness—Omeprazole—Barrett's esophagus	5.62e-05	0.00112	CcSEcCtD
Lansoprazole—CYP4A11—Arachidonic acid metabolism—PTGS2—Barrett's esophagus	5.59e-05	0.00434	CbGpPWpGaD
Lansoprazole—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	5.58e-05	0.00433	CbGpPWpGaD
Lansoprazole—MAPT—Copper homeostasis—TP53—Barrett's esophagus	5.57e-05	0.00432	CbGpPWpGaD
Lansoprazole—Abdominal distension—Esomeprazole—Barrett's esophagus	5.54e-05	0.00111	CcSEcCtD
Lansoprazole—Abdominal distension—Omeprazole—Barrett's esophagus	5.54e-05	0.00111	CcSEcCtD
Lansoprazole—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	5.53e-05	0.00429	CbGpPWpGaD
Lansoprazole—CYP2C8—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	5.51e-05	0.00427	CbGpPWpGaD
Lansoprazole—CYP2D6—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	5.51e-05	0.00427	CbGpPWpGaD
Lansoprazole—Asthma—Omeprazole—Barrett's esophagus	5.5e-05	0.0011	CcSEcCtD
Lansoprazole—Dysphagia—Esomeprazole—Barrett's esophagus	5.5e-05	0.0011	CcSEcCtD
Lansoprazole—Influenza—Omeprazole—Barrett's esophagus	5.5e-05	0.0011	CcSEcCtD
Lansoprazole—Dysphagia—Omeprazole—Barrett's esophagus	5.5e-05	0.0011	CcSEcCtD
Lansoprazole—Influenza—Esomeprazole—Barrett's esophagus	5.5e-05	0.0011	CcSEcCtD
Lansoprazole—Asthma—Esomeprazole—Barrett's esophagus	5.5e-05	0.0011	CcSEcCtD
Lansoprazole—MAPT—BDNF signaling pathway—APC—Barrett's esophagus	5.46e-05	0.00423	CbGpPWpGaD
Lansoprazole—CYP2C9—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	5.46e-05	0.00423	CbGpPWpGaD
Lansoprazole—Pancreatitis—Omeprazole—Barrett's esophagus	5.4e-05	0.00108	CcSEcCtD
Lansoprazole—Pancreatitis—Esomeprazole—Barrett's esophagus	5.4e-05	0.00108	CcSEcCtD
Lansoprazole—Angina pectoris—Omeprazole—Barrett's esophagus	5.36e-05	0.00107	CcSEcCtD
Lansoprazole—Angina pectoris—Esomeprazole—Barrett's esophagus	5.36e-05	0.00107	CcSEcCtD
Lansoprazole—ATP4A—Transmembrane transport of small molecules—SLC9A1—Barrett's esophagus	5.32e-05	0.00412	CbGpPWpGaD
Lansoprazole—Pancytopenia—Omeprazole—Barrett's esophagus	5.23e-05	0.00105	CcSEcCtD
Lansoprazole—Pancytopenia—Esomeprazole—Barrett's esophagus	5.23e-05	0.00105	CcSEcCtD
Lansoprazole—CYP1B1—Biological oxidations—CYP26A1—Barrett's esophagus	5.18e-05	0.00402	CbGpPWpGaD
Lansoprazole—MAPT—Apoptosis—APC—Barrett's esophagus	5.15e-05	0.00399	CbGpPWpGaD
Lansoprazole—Neutropenia—Omeprazole—Barrett's esophagus	5.15e-05	0.00103	CcSEcCtD
Lansoprazole—Dysuria—Omeprazole—Barrett's esophagus	5.15e-05	0.00103	CcSEcCtD
Lansoprazole—Dysuria—Esomeprazole—Barrett's esophagus	5.15e-05	0.00103	CcSEcCtD
Lansoprazole—Neutropenia—Esomeprazole—Barrett's esophagus	5.15e-05	0.00103	CcSEcCtD
Lansoprazole—Upper respiratory tract infection—Esomeprazole—Barrett's esophagus	5.12e-05	0.00102	CcSEcCtD
Lansoprazole—Upper respiratory tract infection—Omeprazole—Barrett's esophagus	5.12e-05	0.00102	CcSEcCtD
Lansoprazole—CYP1B1—Metapathway biotransformation—CYP26A1—Barrett's esophagus	5.11e-05	0.00396	CbGpPWpGaD
Lansoprazole—Pollakiuria—Omeprazole—Barrett's esophagus	5.09e-05	0.00102	CcSEcCtD
Lansoprazole—Pollakiuria—Esomeprazole—Barrett's esophagus	5.09e-05	0.00102	CcSEcCtD
Lansoprazole—Erectile dysfunction—Omeprazole—Barrett's esophagus	5.07e-05	0.00101	CcSEcCtD
Lansoprazole—Erectile dysfunction—Esomeprazole—Barrett's esophagus	5.07e-05	0.00101	CcSEcCtD
Lansoprazole—Photosensitivity reaction—Esomeprazole—Barrett's esophagus	5.02e-05	0.00101	CcSEcCtD
Lansoprazole—Photosensitivity reaction—Omeprazole—Barrett's esophagus	5.02e-05	0.00101	CcSEcCtD
Lansoprazole—Weight increased—Esomeprazole—Barrett's esophagus	5.01e-05	0.001	CcSEcCtD
Lansoprazole—Weight increased—Omeprazole—Barrett's esophagus	5.01e-05	0.001	CcSEcCtD
Lansoprazole—CYP2C19—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	4.92e-05	0.00381	CbGpPWpGaD
Lansoprazole—Infestation NOS—Esomeprazole—Barrett's esophagus	4.91e-05	0.000983	CcSEcCtD
Lansoprazole—Infestation—Esomeprazole—Barrett's esophagus	4.91e-05	0.000983	CcSEcCtD
Lansoprazole—Infestation—Omeprazole—Barrett's esophagus	4.91e-05	0.000983	CcSEcCtD
Lansoprazole—Infestation NOS—Omeprazole—Barrett's esophagus	4.91e-05	0.000983	CcSEcCtD
Lansoprazole—Stevens-Johnson syndrome—Omeprazole—Barrett's esophagus	4.87e-05	0.000974	CcSEcCtD
Lansoprazole—Stevens-Johnson syndrome—Esomeprazole—Barrett's esophagus	4.87e-05	0.000974	CcSEcCtD
Lansoprazole—Renal failure—Esomeprazole—Barrett's esophagus	4.82e-05	0.000966	CcSEcCtD
Lansoprazole—Renal failure—Omeprazole—Barrett's esophagus	4.82e-05	0.000966	CcSEcCtD
Lansoprazole—Jaundice—Omeprazole—Barrett's esophagus	4.78e-05	0.000958	CcSEcCtD
Lansoprazole—Stomatitis—Esomeprazole—Barrett's esophagus	4.78e-05	0.000958	CcSEcCtD
Lansoprazole—Jaundice—Esomeprazole—Barrett's esophagus	4.78e-05	0.000958	CcSEcCtD
Lansoprazole—Stomatitis—Omeprazole—Barrett's esophagus	4.78e-05	0.000958	CcSEcCtD
Lansoprazole—Urinary tract infection—Esomeprazole—Barrett's esophagus	4.77e-05	0.000955	CcSEcCtD
Lansoprazole—Conjunctivitis—Esomeprazole—Barrett's esophagus	4.77e-05	0.000955	CcSEcCtD
Lansoprazole—Urinary tract infection—Omeprazole—Barrett's esophagus	4.77e-05	0.000955	CcSEcCtD
Lansoprazole—Conjunctivitis—Omeprazole—Barrett's esophagus	4.77e-05	0.000955	CcSEcCtD
Lansoprazole—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	4.73e-05	0.00366	CbGpPWpGaD
Lansoprazole—Haematuria—Esomeprazole—Barrett's esophagus	4.68e-05	0.000937	CcSEcCtD
Lansoprazole—Haematuria—Omeprazole—Barrett's esophagus	4.68e-05	0.000937	CcSEcCtD
Lansoprazole—CYP1A2—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	4.66e-05	0.00362	CbGpPWpGaD
Lansoprazole—Hepatobiliary disease—Omeprazole—Barrett's esophagus	4.64e-05	0.000929	CcSEcCtD
Lansoprazole—Hepatobiliary disease—Esomeprazole—Barrett's esophagus	4.64e-05	0.000929	CcSEcCtD
Lansoprazole—Epistaxis—Omeprazole—Barrett's esophagus	4.63e-05	0.000927	CcSEcCtD
Lansoprazole—Epistaxis—Esomeprazole—Barrett's esophagus	4.63e-05	0.000927	CcSEcCtD
Lansoprazole—Sinusitis—Omeprazole—Barrett's esophagus	4.6e-05	0.000922	CcSEcCtD
Lansoprazole—Sinusitis—Esomeprazole—Barrett's esophagus	4.6e-05	0.000922	CcSEcCtD
Lansoprazole—Agranulocytosis—Esomeprazole—Barrett's esophagus	4.58e-05	0.000917	CcSEcCtD
Lansoprazole—Agranulocytosis—Omeprazole—Barrett's esophagus	4.58e-05	0.000917	CcSEcCtD
Lansoprazole—CYP2D6—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	4.52e-05	0.00351	CbGpPWpGaD
Lansoprazole—Bradycardia—Esomeprazole—Barrett's esophagus	4.49e-05	0.000898	CcSEcCtD
Lansoprazole—Bradycardia—Omeprazole—Barrett's esophagus	4.49e-05	0.000898	CcSEcCtD
Lansoprazole—CYP2C9—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	4.48e-05	0.00348	CbGpPWpGaD
Lansoprazole—Rhinitis—Esomeprazole—Barrett's esophagus	4.42e-05	0.000884	CcSEcCtD
Lansoprazole—Rhinitis—Omeprazole—Barrett's esophagus	4.42e-05	0.000884	CcSEcCtD
Lansoprazole—Hepatitis—Esomeprazole—Barrett's esophagus	4.41e-05	0.000882	CcSEcCtD
Lansoprazole—Hepatitis—Omeprazole—Barrett's esophagus	4.41e-05	0.000882	CcSEcCtD
Lansoprazole—Hypoaesthesia—Omeprazole—Barrett's esophagus	4.38e-05	0.000878	CcSEcCtD
Lansoprazole—Hallucination—Omeprazole—Barrett's esophagus	4.38e-05	0.000878	CcSEcCtD
Lansoprazole—Hypoaesthesia—Esomeprazole—Barrett's esophagus	4.38e-05	0.000878	CcSEcCtD
Lansoprazole—Hallucination—Esomeprazole—Barrett's esophagus	4.38e-05	0.000878	CcSEcCtD
Lansoprazole—Pharyngitis—Omeprazole—Barrett's esophagus	4.37e-05	0.000875	CcSEcCtD
Lansoprazole—Pharyngitis—Esomeprazole—Barrett's esophagus	4.37e-05	0.000875	CcSEcCtD
Lansoprazole—MAPT—Integrated Pancreatic Cancer Pathway—APC—Barrett's esophagus	4.36e-05	0.00338	CbGpPWpGaD
Lansoprazole—Urinary tract disorder—Esomeprazole—Barrett's esophagus	4.35e-05	0.000871	CcSEcCtD
Lansoprazole—Urinary tract disorder—Omeprazole—Barrett's esophagus	4.35e-05	0.000871	CcSEcCtD
Lansoprazole—Oedema peripheral—Omeprazole—Barrett's esophagus	4.34e-05	0.000869	CcSEcCtD
Lansoprazole—Oedema peripheral—Esomeprazole—Barrett's esophagus	4.34e-05	0.000869	CcSEcCtD
Lansoprazole—Connective tissue disorder—Esomeprazole—Barrett's esophagus	4.33e-05	0.000867	CcSEcCtD
Lansoprazole—Connective tissue disorder—Omeprazole—Barrett's esophagus	4.33e-05	0.000867	CcSEcCtD
Lansoprazole—Urethral disorder—Omeprazole—Barrett's esophagus	4.32e-05	0.000865	CcSEcCtD
Lansoprazole—Urethral disorder—Esomeprazole—Barrett's esophagus	4.32e-05	0.000865	CcSEcCtD
Lansoprazole—MAPT—BDNF signaling pathway—RELA—Barrett's esophagus	4.27e-05	0.00331	CbGpPWpGaD
Lansoprazole—Visual impairment—Esomeprazole—Barrett's esophagus	4.25e-05	0.00085	CcSEcCtD
Lansoprazole—Visual impairment—Omeprazole—Barrett's esophagus	4.25e-05	0.00085	CcSEcCtD
Lansoprazole—CYP4A11—NRF2 pathway—HGF—Barrett's esophagus	4.21e-05	0.00327	CbGpPWpGaD
Lansoprazole—Erythema multiforme—Omeprazole—Barrett's esophagus	4.17e-05	0.000834	CcSEcCtD
Lansoprazole—Erythema multiforme—Esomeprazole—Barrett's esophagus	4.17e-05	0.000834	CcSEcCtD
Lansoprazole—Eye disorder—Omeprazole—Barrett's esophagus	4.12e-05	0.000824	CcSEcCtD
Lansoprazole—Eye disorder—Esomeprazole—Barrett's esophagus	4.12e-05	0.000824	CcSEcCtD
Lansoprazole—Tinnitus—Omeprazole—Barrett's esophagus	4.11e-05	0.000822	CcSEcCtD
Lansoprazole—Tinnitus—Esomeprazole—Barrett's esophagus	4.11e-05	0.000822	CcSEcCtD
Lansoprazole—CYP4A11—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	4.08e-05	0.00316	CbGpPWpGaD
Lansoprazole—MAPT—Alzheimers Disease—TP53—Barrett's esophagus	3.99e-05	0.00309	CbGpPWpGaD
Lansoprazole—CYP3A4—Irinotecan Pathway—APC—Barrett's esophagus	3.98e-05	0.00309	CbGpPWpGaD
Lansoprazole—Immune system disorder—Omeprazole—Barrett's esophagus	3.98e-05	0.000797	CcSEcCtD
Lansoprazole—Immune system disorder—Esomeprazole—Barrett's esophagus	3.98e-05	0.000797	CcSEcCtD
Lansoprazole—Mediastinal disorder—Omeprazole—Barrett's esophagus	3.97e-05	0.000795	CcSEcCtD
Lansoprazole—Mediastinal disorder—Esomeprazole—Barrett's esophagus	3.97e-05	0.000795	CcSEcCtD
Lansoprazole—CYP1B1—Aryl Hydrocarbon Receptor—RELA—Barrett's esophagus	3.97e-05	0.00308	CbGpPWpGaD
Lansoprazole—Chills—Omeprazole—Barrett's esophagus	3.95e-05	0.000791	CcSEcCtD
Lansoprazole—Chills—Esomeprazole—Barrett's esophagus	3.95e-05	0.000791	CcSEcCtD
Lansoprazole—Alopecia—Omeprazole—Barrett's esophagus	3.89e-05	0.000779	CcSEcCtD
Lansoprazole—Alopecia—Esomeprazole—Barrett's esophagus	3.89e-05	0.000779	CcSEcCtD
Lansoprazole—Mental disorder—Esomeprazole—Barrett's esophagus	3.86e-05	0.000773	CcSEcCtD
Lansoprazole—Mental disorder—Omeprazole—Barrett's esophagus	3.86e-05	0.000773	CcSEcCtD
Lansoprazole—CYP1B1—Aryl Hydrocarbon Receptor—PTGS2—Barrett's esophagus	3.85e-05	0.00299	CbGpPWpGaD
Lansoprazole—Malnutrition—Esomeprazole—Barrett's esophagus	3.84e-05	0.000768	CcSEcCtD
Lansoprazole—Malnutrition—Omeprazole—Barrett's esophagus	3.84e-05	0.000768	CcSEcCtD
Lansoprazole—CYP1A2—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	3.83e-05	0.00297	CbGpPWpGaD
Lansoprazole—CYP4A11—PPARA activates gene expression—PPARG—Barrett's esophagus	3.78e-05	0.00293	CbGpPWpGaD
Lansoprazole—Flatulence—Omeprazole—Barrett's esophagus	3.78e-05	0.000757	CcSEcCtD
Lansoprazole—Flatulence—Esomeprazole—Barrett's esophagus	3.78e-05	0.000757	CcSEcCtD
Lansoprazole—Tension—Omeprazole—Barrett's esophagus	3.76e-05	0.000753	CcSEcCtD
Lansoprazole—Tension—Esomeprazole—Barrett's esophagus	3.76e-05	0.000753	CcSEcCtD
Lansoprazole—Dysgeusia—Esomeprazole—Barrett's esophagus	3.76e-05	0.000752	CcSEcCtD
Lansoprazole—Dysgeusia—Omeprazole—Barrett's esophagus	3.76e-05	0.000752	CcSEcCtD
Lansoprazole—Nervousness—Omeprazole—Barrett's esophagus	3.73e-05	0.000746	CcSEcCtD
Lansoprazole—Nervousness—Esomeprazole—Barrett's esophagus	3.73e-05	0.000746	CcSEcCtD
Lansoprazole—Back pain—Esomeprazole—Barrett's esophagus	3.71e-05	0.000743	CcSEcCtD
Lansoprazole—Back pain—Omeprazole—Barrett's esophagus	3.71e-05	0.000743	CcSEcCtD
Lansoprazole—CYP4A11—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—Barrett's esophagus	3.7e-05	0.00287	CbGpPWpGaD
Lansoprazole—Muscle spasms—Omeprazole—Barrett's esophagus	3.69e-05	0.000738	CcSEcCtD
Lansoprazole—Muscle spasms—Esomeprazole—Barrett's esophagus	3.69e-05	0.000738	CcSEcCtD
Lansoprazole—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	3.65e-05	0.00283	CbGpPWpGaD
Lansoprazole—Vision blurred—Omeprazole—Barrett's esophagus	3.61e-05	0.000724	CcSEcCtD
Lansoprazole—Vision blurred—Esomeprazole—Barrett's esophagus	3.61e-05	0.000724	CcSEcCtD
Lansoprazole—CYP1B1—Arachidonic acid metabolism—PTGS2—Barrett's esophagus	3.61e-05	0.0028	CbGpPWpGaD
Lansoprazole—CYP3A4—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	3.6e-05	0.00279	CbGpPWpGaD
Lansoprazole—Tremor—Omeprazole—Barrett's esophagus	3.59e-05	0.000719	CcSEcCtD
Lansoprazole—Tremor—Esomeprazole—Barrett's esophagus	3.59e-05	0.000719	CcSEcCtD
Lansoprazole—Ill-defined disorder—Esomeprazole—Barrett's esophagus	3.56e-05	0.000712	CcSEcCtD
Lansoprazole—Ill-defined disorder—Omeprazole—Barrett's esophagus	3.56e-05	0.000712	CcSEcCtD
Lansoprazole—Anaemia—Omeprazole—Barrett's esophagus	3.55e-05	0.00071	CcSEcCtD
Lansoprazole—Anaemia—Esomeprazole—Barrett's esophagus	3.55e-05	0.00071	CcSEcCtD
Lansoprazole—Agitation—Esomeprazole—Barrett's esophagus	3.52e-05	0.000706	CcSEcCtD
Lansoprazole—Agitation—Omeprazole—Barrett's esophagus	3.52e-05	0.000706	CcSEcCtD
Lansoprazole—Angioedema—Omeprazole—Barrett's esophagus	3.5e-05	0.000702	CcSEcCtD
Lansoprazole—Angioedema—Esomeprazole—Barrett's esophagus	3.5e-05	0.000702	CcSEcCtD
Lansoprazole—Malaise—Esomeprazole—Barrett's esophagus	3.46e-05	0.000692	CcSEcCtD
Lansoprazole—Malaise—Omeprazole—Barrett's esophagus	3.46e-05	0.000692	CcSEcCtD
Lansoprazole—Vertigo—Esomeprazole—Barrett's esophagus	3.45e-05	0.00069	CcSEcCtD
Lansoprazole—Vertigo—Omeprazole—Barrett's esophagus	3.45e-05	0.00069	CcSEcCtD
Lansoprazole—Leukopenia—Esomeprazole—Barrett's esophagus	3.43e-05	0.000687	CcSEcCtD
Lansoprazole—Leukopenia—Omeprazole—Barrett's esophagus	3.43e-05	0.000687	CcSEcCtD
Lansoprazole—Palpitations—Esomeprazole—Barrett's esophagus	3.39e-05	0.000679	CcSEcCtD
Lansoprazole—Palpitations—Omeprazole—Barrett's esophagus	3.39e-05	0.000679	CcSEcCtD
Lansoprazole—Cough—Esomeprazole—Barrett's esophagus	3.35e-05	0.00067	CcSEcCtD
Lansoprazole—Cough—Omeprazole—Barrett's esophagus	3.35e-05	0.00067	CcSEcCtD
Lansoprazole—Hypertension—Esomeprazole—Barrett's esophagus	3.31e-05	0.000663	CcSEcCtD
Lansoprazole—Hypertension—Omeprazole—Barrett's esophagus	3.31e-05	0.000663	CcSEcCtD
Lansoprazole—MAPT—Integrated Pancreatic Cancer Pathway—PTGS2—Barrett's esophagus	3.31e-05	0.00256	CbGpPWpGaD
Lansoprazole—Arthralgia—Omeprazole—Barrett's esophagus	3.27e-05	0.000654	CcSEcCtD
Lansoprazole—Myalgia—Omeprazole—Barrett's esophagus	3.27e-05	0.000654	CcSEcCtD
Lansoprazole—Myalgia—Esomeprazole—Barrett's esophagus	3.27e-05	0.000654	CcSEcCtD
Lansoprazole—Chest pain—Esomeprazole—Barrett's esophagus	3.27e-05	0.000654	CcSEcCtD
Lansoprazole—Chest pain—Omeprazole—Barrett's esophagus	3.27e-05	0.000654	CcSEcCtD
Lansoprazole—Arthralgia—Esomeprazole—Barrett's esophagus	3.27e-05	0.000654	CcSEcCtD
Lansoprazole—Anxiety—Esomeprazole—Barrett's esophagus	3.25e-05	0.000651	CcSEcCtD
Lansoprazole—Anxiety—Omeprazole—Barrett's esophagus	3.25e-05	0.000651	CcSEcCtD
Lansoprazole—Unspecified disorder of skin and subcutaneous tissue—Esomeprazole—Barrett's esophagus	3.24e-05	0.000649	CcSEcCtD
Lansoprazole—Unspecified disorder of skin and subcutaneous tissue—Omeprazole—Barrett's esophagus	3.24e-05	0.000649	CcSEcCtD
Lansoprazole—Discomfort—Esomeprazole—Barrett's esophagus	3.23e-05	0.000646	CcSEcCtD
Lansoprazole—Discomfort—Omeprazole—Barrett's esophagus	3.23e-05	0.000646	CcSEcCtD
Lansoprazole—Dry mouth—Omeprazole—Barrett's esophagus	3.19e-05	0.000639	CcSEcCtD
Lansoprazole—Dry mouth—Esomeprazole—Barrett's esophagus	3.19e-05	0.000639	CcSEcCtD
Lansoprazole—CYP1A1—Biological oxidations—CYP26A1—Barrett's esophagus	3.19e-05	0.00248	CbGpPWpGaD
Lansoprazole—Confusional state—Omeprazole—Barrett's esophagus	3.16e-05	0.000632	CcSEcCtD
Lansoprazole—Confusional state—Esomeprazole—Barrett's esophagus	3.16e-05	0.000632	CcSEcCtD
Lansoprazole—CYP1A1—Metapathway biotransformation—CYP26A1—Barrett's esophagus	3.15e-05	0.00244	CbGpPWpGaD
Lansoprazole—Anaphylactic shock—Omeprazole—Barrett's esophagus	3.13e-05	0.000627	CcSEcCtD
Lansoprazole—Anaphylactic shock—Esomeprazole—Barrett's esophagus	3.13e-05	0.000627	CcSEcCtD
Lansoprazole—Infection—Omeprazole—Barrett's esophagus	3.11e-05	0.000623	CcSEcCtD
Lansoprazole—Infection—Esomeprazole—Barrett's esophagus	3.11e-05	0.000623	CcSEcCtD
Lansoprazole—Shock—Esomeprazole—Barrett's esophagus	3.08e-05	0.000617	CcSEcCtD
Lansoprazole—Shock—Omeprazole—Barrett's esophagus	3.08e-05	0.000617	CcSEcCtD
Lansoprazole—Nervous system disorder—Esomeprazole—Barrett's esophagus	3.07e-05	0.000615	CcSEcCtD
Lansoprazole—Nervous system disorder—Omeprazole—Barrett's esophagus	3.07e-05	0.000615	CcSEcCtD
Lansoprazole—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Barrett's esophagus	3.07e-05	0.00238	CbGpPWpGaD
Lansoprazole—Thrombocytopenia—Esomeprazole—Barrett's esophagus	3.06e-05	0.000614	CcSEcCtD
Lansoprazole—Thrombocytopenia—Omeprazole—Barrett's esophagus	3.06e-05	0.000614	CcSEcCtD
Lansoprazole—Tachycardia—Omeprazole—Barrett's esophagus	3.06e-05	0.000612	CcSEcCtD
Lansoprazole—Tachycardia—Esomeprazole—Barrett's esophagus	3.06e-05	0.000612	CcSEcCtD
Lansoprazole—Skin disorder—Esomeprazole—Barrett's esophagus	3.04e-05	0.000609	CcSEcCtD
Lansoprazole—Skin disorder—Omeprazole—Barrett's esophagus	3.04e-05	0.000609	CcSEcCtD
Lansoprazole—Hyperhidrosis—Esomeprazole—Barrett's esophagus	3.03e-05	0.000606	CcSEcCtD
Lansoprazole—Hyperhidrosis—Omeprazole—Barrett's esophagus	3.03e-05	0.000606	CcSEcCtD
Lansoprazole—Anorexia—Esomeprazole—Barrett's esophagus	2.98e-05	0.000597	CcSEcCtD
Lansoprazole—Anorexia—Omeprazole—Barrett's esophagus	2.98e-05	0.000597	CcSEcCtD
Lansoprazole—CYP3A4—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	2.96e-05	0.00229	CbGpPWpGaD
Lansoprazole—CYP2C8—Biological oxidations—CYP26A1—Barrett's esophagus	2.93e-05	0.00227	CbGpPWpGaD
Lansoprazole—CYP2C8—Metapathway biotransformation—CYP26A1—Barrett's esophagus	2.89e-05	0.00224	CbGpPWpGaD
Lansoprazole—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Barrett's esophagus	2.87e-05	0.00222	CbGpPWpGaD
Lansoprazole—Musculoskeletal discomfort—Esomeprazole—Barrett's esophagus	2.85e-05	0.000571	CcSEcCtD
Lansoprazole—Musculoskeletal discomfort—Omeprazole—Barrett's esophagus	2.85e-05	0.000571	CcSEcCtD
Lansoprazole—Insomnia—Omeprazole—Barrett's esophagus	2.83e-05	0.000567	CcSEcCtD
Lansoprazole—Insomnia—Esomeprazole—Barrett's esophagus	2.83e-05	0.000567	CcSEcCtD
Lansoprazole—Paraesthesia—Omeprazole—Barrett's esophagus	2.81e-05	0.000563	CcSEcCtD
Lansoprazole—Paraesthesia—Esomeprazole—Barrett's esophagus	2.81e-05	0.000563	CcSEcCtD
Lansoprazole—Dyspnoea—Omeprazole—Barrett's esophagus	2.79e-05	0.000559	CcSEcCtD
Lansoprazole—Dyspnoea—Esomeprazole—Barrett's esophagus	2.79e-05	0.000559	CcSEcCtD
Lansoprazole—Somnolence—Omeprazole—Barrett's esophagus	2.78e-05	0.000557	CcSEcCtD
Lansoprazole—Somnolence—Esomeprazole—Barrett's esophagus	2.78e-05	0.000557	CcSEcCtD
Lansoprazole—Dyspepsia—Omeprazole—Barrett's esophagus	2.76e-05	0.000552	CcSEcCtD
Lansoprazole—Dyspepsia—Esomeprazole—Barrett's esophagus	2.76e-05	0.000552	CcSEcCtD
Lansoprazole—ABCG2—Fluoropyrimidine Activity—TP53—Barrett's esophagus	2.72e-05	0.00211	CbGpPWpGaD
Lansoprazole—Decreased appetite—Omeprazole—Barrett's esophagus	2.72e-05	0.000545	CcSEcCtD
Lansoprazole—Decreased appetite—Esomeprazole—Barrett's esophagus	2.72e-05	0.000545	CcSEcCtD
Lansoprazole—Gastrointestinal disorder—Esomeprazole—Barrett's esophagus	2.7e-05	0.000541	CcSEcCtD
Lansoprazole—Gastrointestinal disorder—Omeprazole—Barrett's esophagus	2.7e-05	0.000541	CcSEcCtD
Lansoprazole—Fatigue—Omeprazole—Barrett's esophagus	2.7e-05	0.00054	CcSEcCtD
Lansoprazole—Fatigue—Esomeprazole—Barrett's esophagus	2.7e-05	0.00054	CcSEcCtD
Lansoprazole—Constipation—Esomeprazole—Barrett's esophagus	2.68e-05	0.000536	CcSEcCtD
Lansoprazole—Constipation—Omeprazole—Barrett's esophagus	2.68e-05	0.000536	CcSEcCtD
Lansoprazole—Pain—Omeprazole—Barrett's esophagus	2.68e-05	0.000536	CcSEcCtD
Lansoprazole—Pain—Esomeprazole—Barrett's esophagus	2.68e-05	0.000536	CcSEcCtD
Lansoprazole—CYP1B1—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	2.63e-05	0.00204	CbGpPWpGaD
Lansoprazole—CYP2C19—Biological oxidations—CYP26A1—Barrett's esophagus	2.61e-05	0.00203	CbGpPWpGaD
Lansoprazole—Feeling abnormal—Omeprazole—Barrett's esophagus	2.58e-05	0.000516	CcSEcCtD
Lansoprazole—Feeling abnormal—Esomeprazole—Barrett's esophagus	2.58e-05	0.000516	CcSEcCtD
Lansoprazole—CYP2C19—Metapathway biotransformation—CYP26A1—Barrett's esophagus	2.58e-05	0.002	CbGpPWpGaD
Lansoprazole—Gastrointestinal pain—Esomeprazole—Barrett's esophagus	2.56e-05	0.000512	CcSEcCtD
Lansoprazole—Gastrointestinal pain—Omeprazole—Barrett's esophagus	2.56e-05	0.000512	CcSEcCtD
Lansoprazole—CYP4A11—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—Barrett's esophagus	2.55e-05	0.00198	CbGpPWpGaD
Lansoprazole—Urticaria—Omeprazole—Barrett's esophagus	2.49e-05	0.000498	CcSEcCtD
Lansoprazole—Urticaria—Esomeprazole—Barrett's esophagus	2.49e-05	0.000498	CcSEcCtD
Lansoprazole—Abdominal pain—Esomeprazole—Barrett's esophagus	2.47e-05	0.000495	CcSEcCtD
Lansoprazole—Body temperature increased—Esomeprazole—Barrett's esophagus	2.47e-05	0.000495	CcSEcCtD
Lansoprazole—Abdominal pain—Omeprazole—Barrett's esophagus	2.47e-05	0.000495	CcSEcCtD
Lansoprazole—Body temperature increased—Omeprazole—Barrett's esophagus	2.47e-05	0.000495	CcSEcCtD
Lansoprazole—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Barrett's esophagus	2.45e-05	0.0019	CbGpPWpGaD
Lansoprazole—CYP1A1—Aryl Hydrocarbon Receptor—RELA—Barrett's esophagus	2.44e-05	0.00189	CbGpPWpGaD
Lansoprazole—CYP2D6—Biological oxidations—CYP26A1—Barrett's esophagus	2.4e-05	0.00186	CbGpPWpGaD
Lansoprazole—CYP2C9—Biological oxidations—CYP26A1—Barrett's esophagus	2.38e-05	0.00185	CbGpPWpGaD
Lansoprazole—CYP1A1—Aryl Hydrocarbon Receptor—PTGS2—Barrett's esophagus	2.37e-05	0.00184	CbGpPWpGaD
Lansoprazole—CYP2D6—Metapathway biotransformation—CYP26A1—Barrett's esophagus	2.37e-05	0.00184	CbGpPWpGaD
Lansoprazole—CYP2C9—Metapathway biotransformation—CYP26A1—Barrett's esophagus	2.35e-05	0.00182	CbGpPWpGaD
Lansoprazole—MAPT—Apoptosis—TP53—Barrett's esophagus	2.33e-05	0.0018	CbGpPWpGaD
Lansoprazole—Hypersensitivity—Esomeprazole—Barrett's esophagus	2.31e-05	0.000462	CcSEcCtD
Lansoprazole—Hypersensitivity—Omeprazole—Barrett's esophagus	2.31e-05	0.000462	CcSEcCtD
Lansoprazole—Asthenia—Esomeprazole—Barrett's esophagus	2.25e-05	0.00045	CcSEcCtD
Lansoprazole—Asthenia—Omeprazole—Barrett's esophagus	2.25e-05	0.00045	CcSEcCtD
Lansoprazole—CYP1A1—Arachidonic acid metabolism—PTGS2—Barrett's esophagus	2.22e-05	0.00172	CbGpPWpGaD
Lansoprazole—Pruritus—Omeprazole—Barrett's esophagus	2.21e-05	0.000443	CcSEcCtD
Lansoprazole—Pruritus—Esomeprazole—Barrett's esophagus	2.21e-05	0.000443	CcSEcCtD
Lansoprazole—MAPT—MAPK Signaling Pathway—TP53—Barrett's esophagus	2.18e-05	0.00169	CbGpPWpGaD
Lansoprazole—Diarrhoea—Esomeprazole—Barrett's esophagus	2.14e-05	0.000429	CcSEcCtD
Lansoprazole—Diarrhoea—Omeprazole—Barrett's esophagus	2.14e-05	0.000429	CcSEcCtD
Lansoprazole—Dizziness—Omeprazole—Barrett's esophagus	2.07e-05	0.000414	CcSEcCtD
Lansoprazole—Dizziness—Esomeprazole—Barrett's esophagus	2.07e-05	0.000414	CcSEcCtD
Lansoprazole—CYP2C8—Arachidonic acid metabolism—PTGS2—Barrett's esophagus	2.04e-05	0.00158	CbGpPWpGaD
Lansoprazole—CYP1A2—Biological oxidations—CYP26A1—Barrett's esophagus	2.04e-05	0.00158	CbGpPWpGaD
Lansoprazole—ABCG2—Transmembrane transport of small molecules—ATP4A—Barrett's esophagus	2.03e-05	0.00157	CbGpPWpGaD
Lansoprazole—CYP1A2—Metapathway biotransformation—CYP26A1—Barrett's esophagus	2.01e-05	0.00156	CbGpPWpGaD
Lansoprazole—Vomiting—Omeprazole—Barrett's esophagus	1.99e-05	0.000398	CcSEcCtD
Lansoprazole—Vomiting—Esomeprazole—Barrett's esophagus	1.99e-05	0.000398	CcSEcCtD
Lansoprazole—Rash—Esomeprazole—Barrett's esophagus	1.97e-05	0.000395	CcSEcCtD
Lansoprazole—Rash—Omeprazole—Barrett's esophagus	1.97e-05	0.000395	CcSEcCtD
Lansoprazole—Dermatitis—Esomeprazole—Barrett's esophagus	1.97e-05	0.000395	CcSEcCtD
Lansoprazole—Dermatitis—Omeprazole—Barrett's esophagus	1.97e-05	0.000395	CcSEcCtD
Lansoprazole—MAPT—Integrated Pancreatic Cancer Pathway—TP53—Barrett's esophagus	1.97e-05	0.00153	CbGpPWpGaD
Lansoprazole—Headache—Esomeprazole—Barrett's esophagus	1.96e-05	0.000393	CcSEcCtD
Lansoprazole—Headache—Omeprazole—Barrett's esophagus	1.96e-05	0.000393	CcSEcCtD
Lansoprazole—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Barrett's esophagus	1.89e-05	0.00147	CbGpPWpGaD
Lansoprazole—Nausea—Esomeprazole—Barrett's esophagus	1.86e-05	0.000372	CcSEcCtD
Lansoprazole—Nausea—Omeprazole—Barrett's esophagus	1.86e-05	0.000372	CcSEcCtD
Lansoprazole—CYP2C19—Arachidonic acid metabolism—PTGS2—Barrett's esophagus	1.82e-05	0.00141	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism—PTGES—Barrett's esophagus	1.82e-05	0.00141	CbGpPWpGaD
Lansoprazole—CYP2C9—Arachidonic acid metabolism—PTGS2—Barrett's esophagus	1.66e-05	0.00128	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	1.62e-05	0.00125	CbGpPWpGaD
Lansoprazole—CYP2C18—Metabolism—PTGES—Barrett's esophagus	1.59e-05	0.00123	CbGpPWpGaD
Lansoprazole—CYP3A4—Biological oxidations—CYP26A1—Barrett's esophagus	1.57e-05	0.00122	CbGpPWpGaD
Lansoprazole—CYP1A2—Aryl Hydrocarbon Receptor—RELA—Barrett's esophagus	1.56e-05	0.00121	CbGpPWpGaD
Lansoprazole—CYP3A4—Metapathway biotransformation—CYP26A1—Barrett's esophagus	1.55e-05	0.0012	CbGpPWpGaD
Lansoprazole—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—Barrett's esophagus	1.51e-05	0.00117	CbGpPWpGaD
Lansoprazole—CYP1A1—PPARA activates gene expression—PPARG—Barrett's esophagus	1.5e-05	0.00116	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	1.48e-05	0.00115	CbGpPWpGaD
Lansoprazole—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—Barrett's esophagus	1.47e-05	0.00114	CbGpPWpGaD
Lansoprazole—CYP1A2—Arachidonic acid metabolism—PTGS2—Barrett's esophagus	1.42e-05	0.0011	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism—CYP26A1—Barrett's esophagus	1.38e-05	0.00107	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	1.32e-05	0.00103	CbGpPWpGaD
Lansoprazole—ABCG2—Transmembrane transport of small molecules—SLC9A1—Barrett's esophagus	1.24e-05	0.000962	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	1.21e-05	0.000936	CbGpPWpGaD
Lansoprazole—CYP2C18—Metabolism—CYP26A1—Barrett's esophagus	1.2e-05	0.000932	CbGpPWpGaD
Lansoprazole—ABCB1—Allograft Rejection—CXCL8—Barrett's esophagus	1.19e-05	0.000925	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—PTGES—Barrett's esophagus	1.17e-05	0.000907	CbGpPWpGaD
Lansoprazole—ABCB1—Transmembrane transport of small molecules—ATP4A—Barrett's esophagus	1.09e-05	0.000849	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—PTGES—Barrett's esophagus	1.06e-05	0.000825	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	1.03e-05	0.0008	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	1.02e-05	0.000788	CbGpPWpGaD
Lansoprazole—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—Barrett's esophagus	1.01e-05	0.000785	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism—SLC9A1—Barrett's esophagus	9.92e-06	0.000769	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—CYP26A1—Barrett's esophagus	8.86e-06	0.000687	CbGpPWpGaD
Lansoprazole—CYP2C18—Metabolism—SLC9A1—Barrett's esophagus	8.67e-06	0.000672	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—CYP26A1—Barrett's esophagus	8.06e-06	0.000625	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	8e-06	0.00062	CbGpPWpGaD
Lansoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—APC—Barrett's esophagus	7.99e-06	0.00062	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—PTGES—Barrett's esophagus	7.2e-06	0.000559	CbGpPWpGaD
Lansoprazole—ABCB1—Transmembrane transport of small molecules—SLC9A1—Barrett's esophagus	6.71e-06	0.00052	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—PTGES—Barrett's esophagus	6.6e-06	0.000512	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	6.55e-06	0.000508	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—SLC9A1—Barrett's esophagus	6.39e-06	0.000495	CbGpPWpGaD
Lansoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—Barrett's esophagus	6.07e-06	0.000471	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—PTGES—Barrett's esophagus	5.89e-06	0.000457	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—SLC9A1—Barrett's esophagus	5.81e-06	0.000451	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—PTGES—Barrett's esophagus	5.75e-06	0.000446	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—CYP26A1—Barrett's esophagus	5.46e-06	0.000423	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—PTGES—Barrett's esophagus	5.42e-06	0.00042	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—PTGES—Barrett's esophagus	5.37e-06	0.000417	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	5.15e-06	0.0004	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—CYP26A1—Barrett's esophagus	5e-06	0.000388	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—PTGES—Barrett's esophagus	4.59e-06	0.000356	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism—PPARG—Barrett's esophagus	4.53e-06	0.000351	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—CYP26A1—Barrett's esophagus	4.47e-06	0.000346	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—CYP26A1—Barrett's esophagus	4.36e-06	0.000338	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—CYP26A1—Barrett's esophagus	4.11e-06	0.000319	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—CYP26A1—Barrett's esophagus	4.07e-06	0.000316	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	4.03e-06	0.000313	CbGpPWpGaD
Lansoprazole—CYP2C18—Metabolism—PPARG—Barrett's esophagus	3.96e-06	0.000307	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—SLC9A1—Barrett's esophagus	3.94e-06	0.000305	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	3.7e-06	0.000287	CbGpPWpGaD
Lansoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—Barrett's esophagus	3.61e-06	0.00028	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—SLC9A1—Barrett's esophagus	3.61e-06	0.00028	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism—PTGS2—Barrett's esophagus	3.56e-06	0.000276	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—PTGES—Barrett's esophagus	3.54e-06	0.000275	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—CYP26A1—Barrett's esophagus	3.48e-06	0.00027	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	3.3e-06	0.000256	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—SLC9A1—Barrett's esophagus	3.22e-06	0.00025	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	3.17e-06	0.000246	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—SLC9A1—Barrett's esophagus	3.14e-06	0.000244	CbGpPWpGaD
Lansoprazole—CYP2C18—Metabolism—PTGS2—Barrett's esophagus	3.11e-06	0.000241	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	3.01e-06	0.000233	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—SLC9A1—Barrett's esophagus	2.96e-06	0.00023	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—SLC9A1—Barrett's esophagus	2.94e-06	0.000228	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—PPARG—Barrett's esophagus	2.92e-06	0.000226	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	2.91e-06	0.000226	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—CYP26A1—Barrett's esophagus	2.69e-06	0.000208	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—PPARG—Barrett's esophagus	2.65e-06	0.000206	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	2.6e-06	0.000201	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	2.57e-06	0.000199	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—SLC9A1—Barrett's esophagus	2.51e-06	0.000195	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	2.37e-06	0.000184	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—PTGS2—Barrett's esophagus	2.29e-06	0.000178	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—PTGS2—Barrett's esophagus	2.09e-06	0.000162	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	2.02e-06	0.000157	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—SLC9A1—Barrett's esophagus	1.94e-06	0.00015	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—PPARG—Barrett's esophagus	1.8e-06	0.000139	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—PPARG—Barrett's esophagus	1.65e-06	0.000128	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—PPARG—Barrett's esophagus	1.47e-06	0.000114	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—PPARG—Barrett's esophagus	1.43e-06	0.000111	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—PTGS2—Barrett's esophagus	1.41e-06	0.00011	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—PPARG—Barrett's esophagus	1.35e-06	0.000105	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—PPARG—Barrett's esophagus	1.34e-06	0.000104	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—PTGS2—Barrett's esophagus	1.3e-06	0.0001	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—PTGS2—Barrett's esophagus	1.16e-06	8.97e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—PPARG—Barrett's esophagus	1.15e-06	8.88e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—PTGS2—Barrett's esophagus	1.13e-06	8.75e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—PTGS2—Barrett's esophagus	1.06e-06	8.25e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—PTGS2—Barrett's esophagus	1.05e-06	8.18e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—PTGS2—Barrett's esophagus	9.01e-07	6.99e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—PPARG—Barrett's esophagus	8.84e-07	6.85e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—PTGS2—Barrett's esophagus	6.95e-07	5.39e-05	CbGpPWpGaD
